NVRO: Nevro Corp Company Profile & Statistics

About

Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.

Info & Links

CEO

Kevin Thornal

Headquarters

1800 BRIDGE PARKWAY
REDWOOD CITY, CA 94065, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

1,215

Nevro Corp Statistics

Valuation Measures

Market Capitalization²

146.51M

Enterprise Value

296.80M

Enterprise Value/EBITDA(ttm)

-4.03

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.36

Price to Book(mrq)

0.55

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

67.94%

Operating Margin(ttm)

-15.71%

Profit Margin(ttm)

-16.82%

Return on Equity(ttm)

-23.52%

Return on Invested Capital(ttm)

-14.58%

Return on Assets(ttm)

-10.83%

Income Statement

Revenue(ttm)

419.15M

Revenue Per Share(ttm)

11.19

Gross Profit(ttm)

285.09M

EBITDA(ttm)³

-73.71M

Net Income Available to Common(ttm)

-69.31M

Diluted EPS(ttm)

-1.89

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

-79.29%

S&P 500 52-Week Change

26.70%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

37.47M

Dividend Yield

0.00%

Float⁴

36.27M

% Held by Insiders

3.20%

% Held by Institutions

95.52%

Balance Sheet

Total Cash(mrq)

277.04M

Total Cash Per Share(mrq)

7.39

Total Debt(mrq)

222.27M

Total Debt/Equity(mrq)

81.23%

Current Ratio(mrq)

5.02%

Quick Ratio(mrq)

3.76%

Book Value Per Share(mrq)

7.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.02

Free Cash Flow(ytd)

-45.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NVRO

Nevro Corp

Nevro Corp Profile